spacer
home > ict > summer 2019 > patient recruitment in the digital age
PUBLICATIONS
International Clinical Trials

Patient Recruitment in the Digital Age





It is estimated that 4.4 billion people globally use the internet and another 3.5 billion people are engaged on a social media platform (1). On Facebook alone, 2.4 billion monthly active users engage with each other across thousands of online communities (2). People use the internet and social media to interact with family and friends, catch up on the latest news, and connect with people who have the same interests; more importantly, people use the internet to search for health-related information.

More than 80% of social media users seek health-related information, and 40% say that information found via social media affects the way they deal with their health (according to Mediabistro). These people are looking for this specifically, giving recruiters an opportunity they didnít have before. Instead of pushing out information to everyone on TV, they can target people searching for it. Online seekers are not just millennials or young people; they range in all age groups. The previously held belief that older patients do not search online has been proven incorrect time and again. In fact, the 65-plus age group is the fastest growing population to adopt online platforms, and a recent AARP poll of 1,509 US adults showed that 52% of people between the ages of 50-64 had Facebook pages (3).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the authors


Miaesha Campbell, Director, Patient Recruitment, oversees the global patient recruitment department at Medpace and leads her team to drive patient recruitment and retention solutions for clinical trials. Miaesha graduated from California State University at Dominquez Hills in May 2002, earning a Bachelor of Arts degree in English and a Minor in Communications. Her early career was spent in public relations, and she was recruited to support the marketing of clinical trial programmes in 2007.




Amanda Siegert is a Senior Manager of Patient Recruitment at Medpace. She has been working in research for 14 years, the last 10 specialising in patient recruitment. Amanda graduated from the University of California at Santa Barbara with a BA in Social-Cultural Anthropology. She started her career in research at Inamed Aesthetics and Allergan working in regulatory and as a CRA. Amanda found her niche in patient recruitment, combining her love for people and culture with her research experience. She worked at MMG for 8 years focusing on grass roots community outreach and physician networking tactics for patient recruitment before moving to Medpace.


Print this page
Send to a friend
Privacy statement
News and Press Releases

Discussing developments on Highly Potent APIs with industry expert, Richard Arnett for the HPAPI USA conference 2019

Ahead of the 2019 HPAPI USA Conference taking place in Boston on 21st Ė 22nd October, SMi caught up with Richard Arnett, Manager, Industrial Hygiene, Pharmascience who is speaking on Day Two of the agenda. Richard shared his thoughts on how the industry has developed and briefly touched on what he will be discussing in October.
More info >>

White Papers

Time lapse photography to demonstrate the potential antimicrobial abilities of Dycem contamination control flooring

Dycem

A defined volume of bioluminescent reporter bacteria was deposited onto 20 mm x 20 mm coupons of Dycem flooring, vinyl tile and ITW Alma tacky mat. Through monitoring of bacterial bioluminescence, metabolic inhibition was observed on all three surfaces however the effect occurred more rapidly on Dycem flooring than on vinyl or ITW Alma. Recovery counts after three hours of exposure to the floor surfaces showed between a 65% and 100% decrease in the number of viable organisms recovered from Dycem flooring compared to controls. On vinyl and ITW Alma flooring, there were slight increases in the number of viable survivors recovered compared to controls. Dycem flooring inhibited the metabolic activity and reduced the number of viable survivors recovered of Salmonella enterica Serovar Typhimurium DT104 pGLITE. It remains unclear as to whether this effect is attributable to the impregnated biocide or rapid drying of the inoculum on this surface.
More info >>

 
Industry Events

SCOPE Summit for Clinical Ops Executives

18-21 February 2020, Hyatt Regency, Orlando, Florida, US

Celebrating its 11th successful year, SCOPE Summit 2020 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-depth discussions in 20 different conferences, 3 plenary keynote sessions, the annual Participant Engagement Awards, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, management and operations
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement